BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20595029)

  • 1. Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection.
    Norton LW; Park J; Babensee JE
    J Control Release; 2010 Sep; 146(3):341-8. PubMed ID: 20595029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells support a proliferative antigen-specific T-cell response in the presence of poly(lactic-co-glycolic acid).
    Srinivasan S; Elizabeth Babensee J
    J Biomed Mater Res A; 2021 Nov; 109(11):2269-2279. PubMed ID: 33960123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
    Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
    Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells.
    Han R; Zhu J; Yang X; Xu H
    J Biomed Mater Res A; 2011 Jan; 96(1):142-9. PubMed ID: 21105162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
    Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
    J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of antigen-specific immune tolerance using biodegradable nanoparticles containing antigen and dexamethasone.
    Kim SH; Moon JH; Jeong SU; Jung HH; Park CS; Hwang BY; Lee CK
    Int J Nanomedicine; 2019; 14():5229-5242. PubMed ID: 31371958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation.
    Yoshida M; Babensee JE
    J Biomed Mater Res A; 2006 Nov; 79(2):393-408. PubMed ID: 16886225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune responses to model antigen co-delivered with biomaterials used in tissue engineering.
    Matzelle MM; Babensee JE
    Biomaterials; 2004 Jan; 25(2):295-304. PubMed ID: 14585717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
    Han HD; Byeon Y; Kang TH; Jung ID; Lee JW; Shin BC; Lee YJ; Sood AK; Park YM
    Int J Nanomedicine; 2016; 11():5729-5742. PubMed ID: 27843314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen.
    Bennewitz NL; Babensee JE
    Biomaterials; 2005 Jun; 26(16):2991-9. PubMed ID: 15603794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of integrins in the recognition and response of dendritic cells to biomaterials.
    Rogers TH; Babensee JE
    Biomaterials; 2011 Feb; 32(5):1270-9. PubMed ID: 21030075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Responsive Poly(D,L-lactic-co-glycolic acid) Nanoparticles with Rapid Antigen Release Behavior Promote Immune Response.
    Liu Q; Chen X; Jia J; Zhang W; Yang T; Wang L; Ma G
    ACS Nano; 2015 May; 9(5):4925-38. PubMed ID: 25898266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
    San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
    Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.
    San Román B; Gómez S; Irache JM; Espuelas S
    J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential functional effects of biomaterials on dendritic cell maturation.
    Park J; Babensee JE
    Acta Biomater; 2012 Oct; 8(10):3606-17. PubMed ID: 22705044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dendritic Cells-Targeting Nano-Vaccine by Coupling Polylactic-Co-Glycolic Acid-Encapsulated Allergen with Mannan Induces Regulatory T Cells.
    Wen H; Qu L; Zhang Y; Xu B; Ling S; Liu X; Luo Y; Huo D; Li W; Yao X
    Int Arch Allergy Immunol; 2021; 182(9):777-787. PubMed ID: 34289474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.